Skip to main content

Table 6 Adjusted hazard ratios for the associations between changes in strenuous recreational physical activity levels and invasive breast cancer

From: Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study

RPA at baselinea, h/wk/y

RPA at 10-year follow-upb, h/wk/y

Overall

Observed person-years

Cases, no.

Adjusted HR (95 % CI)

Breast cancer overall

 No change

  Low (≤0.50)

Low (≤0.50)

24,028

396,185

692

Referent

  Intermediate (0.51–3.50)

Intermediate (0.51–3.50)

6273

104,479

155

1.01 (0.84–1.21)

  High (≥3.51)

High (≥3.51)

2462

41,105

42

0.71 (0.52–0.98)

 Increasing

  Low (≤0.50)

Intermediate (0.51–3.50)

5640

93,840

127

0.86 (0.71–1.04)

  Low (≤0.50)

High (≥3.51)

1267

21,076

34

1.03 (0.72–1.45)

  Intermediate (0.51–3.50)

High (≥3.51)

1751

29,121

40

0.89 (0.64–1.23)

 Decreasing

  Intermediate (0.51–3.50)

Low (≤0.50)

8436

139,718

209

0.96 (0.82–1.12)

  High (≥3.51)

Low (≤0.50)

2212

36,515

58

1.00 (0.76–1.32)

  High (≥3.51)

Intermediate (0.51–3.50)

2617

43,519

46

0.75 (0.55–1.02)

  1. Results are for 54,686 women who completed baseline and 10-year follow-up questionnaires regarding RPA in recent 3 years in the California Teachers Study, 1995–2012. HRs are from multivariable Cox proportional hazards regression models using age (in days) as the time metric and stratified by age (in years) with the adjustment for race, family history of breast cancer in first-degree relatives, combined age at first full-term pregnancy and parity variable, combined menopausal status and MHT use variable, BMI at baseline, history of smoking, alcohol intake during the past year of baseline, screening mammogram in the past 2 years of baseline, history of a breast biopsy, and a corresponding changes in level of moderate RPA variable
  2. Abbreviations: BMI body mass index, CI confidence interval, HR hazard ratio, h/wk/y hour/week/year, MHT menopausal hormone therapy, RPA recreational physical activity
  3. aRPA during the 3 years prior to baseline
  4. bRPA during the 3 years prior to 10-year follow-up